HomeCompareCTWS vs ABBV

CTWS vs ABBV: Dividend Comparison 2026

CTWS yields 4.00% · ABBV yields 3.67%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ABBV wins by $11.9K in total portfolio value
10 years
CTWS
CTWS
● Live price
4.00%
Share price
$50.00
Annual div
$2.00
5Y div CAGR
5%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$28.0K
Annual income
$899.19
Full CTWS calculator →
ABBV
AbbVie Inc.
● Live price
3.67%
Share price
$168.90
Annual div
$6.20
5Y div CAGR
8.9%
Payout ratio
58%
After 10 yrs · $10,000 · DRIP
Portfolio value
$39.9K
Annual income
$1,154.43
Full ABBV calculator →

Portfolio growth — CTWS vs ABBV

📍 ABBV pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCTWSABBV
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CTWS + ABBV cover 4 of 12 monthsgood coverage

Jan
ABBV
Feb
Mar
Apr
ABBV
May
Jun
Jul
ABBV
Aug
Sep
Oct
ABBV
Nov
Dec
CTWS pays
ABBV pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CTWS
Annual income on $10K today (after 15% tax)
$340.00/yr
After 10yr DRIP, annual income (after tax)
$764.31/yr
ABBV
Annual income on $10K today (after 15% tax)
$312.02/yr
After 10yr DRIP, annual income (after tax)
$981.27/yr
At 15% tax rate, ABBV beats the other by $216.95/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CTWS + ABBV for your $10,000?

CTWS: 50%ABBV: 50%
100% ABBV50/50100% CTWS
Portfolio after 10yr
$34.0K
Annual income
$1,026.82/yr
Blended yield
3.02%
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CTWS buys
0
ABBV buys
0
No recent congressional trades found for CTWS or ABBV in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCTWSABBV
Forward yield4.00%3.67%
Annual dividend / share$2.00$6.20
Payout ratio50%58%
1-year div growth5%4.7%
5-year div CAGR5%8.9%
Portfolio after 10y$28.0K$39.9K
Annual income after 10y$899.19$1,154.43
Total dividends collected$6.4K$7.2K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: CTWS vs ABBV ($10,000, DRIP)

YearCTWS PortfolioCTWS Income/yrABBV PortfolioABBV Income/yrGap
1← crossover$11,120$420.00$11,520$399.75$400.00ABBV
2$12,357$458.31$13,261$450.98$904.00ABBV
3$13,721$499.76$15,255$508.41$1.5KABBV
4$15,227$544.58$17,536$572.74$2.3KABBV
5$16,885$593.02$20,145$644.78$3.3KABBV
6$18,713$645.34$23,126$725.38$4.4KABBV
7$20,724$701.81$26,532$815.52$5.8KABBV
8$22,938$762.73$30,420$916.26$7.5KABBV
9$25,372$828.41$34,855$1,028.80$9.5KABBV
10$28,047$899.19$39,914$1,154.43$11.9KABBV

CTWS vs ABBV: Complete Analysis 2026

CTWSStock

CTWS is a dividend-paying stock. Use this calculator to estimate your future dividend income, DRIP compounding returns, and passive income potential from investing in CTWS shares.

Full CTWS Calculator →

ABBVHealthcare

AbbVie is a pharmaceutical giant best known for Humira and newer blockbusters Skyrizi and Rinvoq. A Dividend Aristocrat with 52+ years of consecutive dividend increases. Strong free cash flow generation supports its above-average yield. The company's diversified pipeline reduces dependence on any single drug.

Full ABBV Calculator →
📬

Get this CTWS vs ABBV comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CTWS vs SCHDCTWS vs JEPICTWS vs OCTWS vs KOCTWS vs MAINCTWS vs JNJCTWS vs MRKCTWS vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.